Dr. Kevin K. Suk, MD

Dr. Suk practices at Acuity Eye Group in Garden Grove, California.

Dr. Suk's NPI, 1326257569, was assigned on May 22, 2007. Dr. Suk graduated from Loma Linda University School Of Medicine in 2005. Dr. Suk holds California license A114509.

Dr. Suk's primary practice is Acuity Eye Group, at 12888 Buaro St, Garden Grove, CA 92840 in Orange County. The practice phone is (800) 898-2020.

Dr. Suk's primary practice is Acuity Eye Group in Garden Grove, California. Dmand AI also links Dr. Suk to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suk practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Suk's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Suk is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Suk's licenses on file in 3 states: California, Florida and Michigan.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Suk treats.

CMS data shows 5,713 Medicare services from Dr. Suk across 15 procedure codes in 2024, for 689 Medicare patients. Medicare paid $816,037 for them. Every service was in an office.

CMS counts 689 Medicare patients who saw Dr. Suk in 2024. The largest group is 75 to 84, with 270 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 66% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Suk's median patient age at 71, with 51% women.

In 2024, Dr. Suk wrote 3,918 Medicare Part D claims for 672 patients. 64% of them were for generic drugs. CMS names the drug for 3,852 of them, across 28 drugs with 11 or more claims each, at $465,960 in total drug cost. In 2023, CMS named 3,712 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Suk for performance year 2024, reported individually. Dr. Suk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Suk in 2010. 2010 was the busiest year, with 2. The most frequent topics are Retinal Detachment, Visual Acuity and Drainage. Dr. Suk's most frequent co-authors are Jennifer A. Dunbar, MD, Harry W. Flynn, MD and Anthony Liu, MD.

CMS Open Payments shows 27 general payments to Dr. Suk from 14 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $148.

Dmand AI lists 1 award for Dr. Suk, most recently CMS Stage 1 EHR in 2013.

Dr. Suk graduated from Loma Linda University School Of Medicine in 2005.

Dr. Suk is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.